AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹81 Cr | ₹78 Cr | ₹76 Cr | ₹71 Cr | ₹72 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of AARTI DRUGS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹81 Cr |
| Mar2025 | ₹78 Cr |
| Mar2024 | ₹76 Cr |
| Mar2023 | ₹71 Cr |
| Mar2022 | ₹72 Cr |
How is Deferred Tax Assets / Liabilities of AARTI DRUGS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹81 Cr | 3.88 | |
| Mar2025 | ₹78 Cr | 3.34 | |
| Mar2024 | ₹76 Cr | 6.68 | |
| Mar2023 | ₹71 Cr | -2.02 | |
| Mar2022 | ₹72 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,771.6 Cr | -0.5% | -1.9% | -15.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -0.5% |
-1.9% |
-15.6% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses